Commerzbank Aktiengesellschaft’s AbbVie ABBV Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-42,000	Closed	-$86K	–	101
2020 Q1	$86K	Buy	+42,000	New	+$3.58M	﹤0.01%	419
2019 Q3	–	Sell	-30,600	Closed	-$10K	–	833
2019 Q2	$10K	Buy	+30,600	New	+$2.41M	﹤0.01%	1039

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ABBV Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft reduced its AbbVie (ABBV) stake by 46% in Q2 2026, selling an estimated $7.06M and leaving 39,227 shares worth $9.87M. The position accounts for 0.2% of the portfolio, ranked #62.

Commerzbank Aktiengesellschaft first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. The position peaked at $62.6M in Q2 2013. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Commerzbank Aktiengesellschaft held 39,227 shares of AbbVie worth $9.87M as of Q2 2026.
Commerzbank Aktiengesellschaft sold 32,834 AbbVie shares in Q2 2026, an estimated $7.06M.
AbbVie made up 0.2% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #62 holding.
Commerzbank Aktiengesellschaft first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
Commerzbank Aktiengesellschaft's AbbVie position peaked at $62.6M in Q2 2013.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.